These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8938538)

  • 1. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.
    Beinker NK; Voigt MD; Arendse M; Smit J; Stander IA; Kirsch RE
    J Hepatol; 1996 Nov; 25(5):633-8. PubMed ID: 8938538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.
    Lin TJ; Liao LY; Lin SY; Lin CL; Chang TA
    World J Gastroenterol; 2006 Aug; 12(30):4897-901. PubMed ID: 16937477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Dilemma for Low Viremia with Significant Fibrosis; is Hepatitis B Virus DNA Threshold Level a Good Indicator for Predicting Liver Damage?
    Yenilmez E; Çetinkaya RA; Tural E
    Balkan Med J; 2018 Jul; 35(4):326-332. PubMed ID: 29726399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
    Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
    J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload in patients with chronic hepatitis C: a clinicopathologic study.
    Haque S; Chandra B; Gerber MA; Lok AS
    Hum Pathol; 1996 Dec; 27(12):1277-81. PubMed ID: 8958298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].
    Moon JH; Park SH; Oh KC; Jung JO; Shin WG; Kim JP; Kim KO; Park CH; Hahn T; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK; Jun SY
    Korean J Gastroenterol; 2006 Jun; 47(6):432-9. PubMed ID: 16809950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
    Wu SF; Peng CT; Wu KH; Tsai CH
    Hemoglobin; 2006; 30(2):215-8. PubMed ID: 16798646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
    Banner BF; Barton AL; Cable EE; Smith L; Bonkovsky HL
    Mod Pathol; 1995 Apr; 8(3):232-8. PubMed ID: 7542385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum aminotransferase levels and histological disease in chronic hepatitis C.
    Michielsen PP; Hauben EI; Ramon AM; Van Marck EA; Pelckmans PA
    Acta Gastroenterol Belg; 1997; 60(1):11-4. PubMed ID: 9144972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
    Barton AL; Banner BF; Cable EE; Bonkovsky HL
    Am J Clin Pathol; 1995 Apr; 103(4):419-24. PubMed ID: 7537017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.
    Ikura Y; Morimoto H; Johmura H; Fukui M; Sakurai M
    Am J Gastroenterol; 1996 Jul; 91(7):1367-73. PubMed ID: 8677997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.